Minerva to price IPO of 5,454,545 shares between $10.00 and $12.00

Jefferies is the bookrunner; Baird, JMP Securities also to assist

By Devika Patel

Knoxville, Tenn., June 10 – Minerva Neurosciences, Inc. will sell 5,454,545 common shares in its initial public offering with a 30-day greenshoe option of 818,182 additional shares, according to a Form S-1/A filed Tuesday with the Securities and Exchange Commission. The deal was announced on April 9.

The shares will be sold at a price expected to fall between $10.00 and $12.00 per share.

Jefferies is the bookrunning manager. Baird and JMP Securities are the co-managers.

Proceeds will be used for clinical development, debt repayment, working capital and general corporate purposes.

The clinical-stage biopharmaceutical company is based in Cambridge, Mass. The company intends to list its common stock on the Nasdaq under the symbol “NERV.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.